TEVJF Earnings Reports, EPS & Revenue History
Quarterly EPS and revenue vs. estimates for Teva Pharmaceutical Industries Limited. Review beat/miss history, upcoming consensus figures, and earnings call transcripts when available.
EPS and Earnings Announcement
Latest Quarterly EPS
Next Earnings Announcement
Unlock for free
Already registered? Sign in
EPS vs. Estimates
Green band = beat vs estimate · Red band = miss · Lines show actual and consensus EPS.
EPS & Revenue vs. Estimates
Upgrade| Date | EPS Actual | EPS Est. | EPS Diff. |
|---|---|---|---|
Apr 29, 2026 | 0.50 | 0.45 | +0.05 |
Jan 28, 2026 | 0.93 | 0.64 | +0.30 |
Nov 5, 2025 | 0.77 | 0.68 | +0.08 |
Jul 30, 2025 | — | — | — |
May 7, 2025 | — | — | — |
Jan 29, 2025 | — | — | — |
Nov 6, 2024 | — | — | — |
Jul 31, 2024 | — | — | — |
May 8, 2024 | — | — | — |
Jan 31, 2024 | — | — | — |
Nov 8, 2023 | — | — | — |
Aug 2, 2023 | — | — | — |
May 10, 2023 | — | — | — |
Feb 8, 2023 | — | — | — |
Nov 3, 2022 | — | — | — |
Jul 26, 2022 | — | — | — |
May 3, 2022 | — | — | — |
Feb 9, 2022 | — | — | — |
Oct 27, 2021 | — | — | — |
Jul 28, 2021 | — | — | — |
Apr 28, 2021 | — | — | — |
Feb 10, 2021 | — | — | — |
Nov 5, 2020 | — | — | — |
Aug 5, 2020 | — | — | — |
May 7, 2020 | — | — | — |
Feb 12, 2020 | — | — | — |
Nov 7, 2019 | — | — | — |
Aug 7, 2019 | — | — | — |
May 2, 2019 | — | — | — |
Nov 2, 2017 | — | — | — |
Aug 3, 2017 | — | — | — |
May 11, 2017 | — | — | — |
Feb 13, 2017 | — | — | — |
Aug 4, 2016 | — | — | — |
May 9, 2016 | — | — | — |
Feb 11, 2016 | — | — | — |
Oct 29, 2015 | — | — | — |
Jul 30, 2015 | — | — | — |
Apr 30, 2015 | — | — | — |
Feb 5, 2015 | — | — | — |
Oct 30, 2014 | — | — | — |
Earnings Call Transcripts
UpgradeEarnings Call Transcripts Require Subscription
Access to earnings call transcripts and AI-powered summaries is available for Pro, Premium, and Enterprise subscribers.
View Pricing PlansRevenue Breakdown
Want to understand TEVJF's revenue sources? Explore detailed revenue breakdowns by product line and geographic region to see what's driving the company's top line.
View Revenue Breakdown